Role of radium-223 discontinuation due to adverse events in castration-resistant prostate cancer patients. A retrospective monocentric analysis.

Fabio Turco,Marcello Tucci,Tiziana Angusti,Antonella Parente,Rosario Francesco Di Stefano, Susanna Urban,Chiara Pisano,Alessandro Samuelly,Alessandro Audisio,Marco Audisio,Elena Parlagreco,Antonio Ungaro,Giorgio Vittorio Scagliotti,Massimo Di Maio,Consuelo Buttigliero

Tumori（2023）

引用 1|浏览38

暂无评分

摘要

Discontinuation due to toxicity is associated with worse outcomes in mCRPC patients treated with Ra-223. To reduce the risk of developing toxicities that may compromise treatment efficacy, Ra-223 should be used early in mCRPC patients.

查看译文

关键词

Radium 223,castration resistant prostate cancer,prognostic factor,prostate cancer,toxicity

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要